Sex differences in myocardial infarction care and outcomes: a longitudinal Scottish National Data-Linkage Study
- PMID: 39592008
- DOI: 10.1093/eurjpc/zwae333
Sex differences in myocardial infarction care and outcomes: a longitudinal Scottish National Data-Linkage Study
Abstract
Aims: We investigate sex disparities in management and outcomes of myocardial infarction (MI) in contemporary practice in Scotland.
Methods and results: This was a longitudinal cohort study including all MI admissions aged 45-80 years across Scotland between 2010-2016 and 2:1 age, sex, and general practice-matched general population controls. Participants were followed up until the end of 2021. We analysed in-hospital outcomes (percutaneous coronary intervention, secondary prevention and mortality) using Poisson regressions, adjusting for age, comorbidities, and ST-elevation. We used Royston-Parmar models for long-term outcomes (all-cause and cardiovascular mortality, incident cardiovascular events), adjusting for age, comorbidities, and secondary prevention. Of a total 47 063 MI patients, 15 776 (33.5%) were women. Median (inter-quartile range) age was 66 (57, 73) years. Compared to men, women were older and more comorbid, but were less likely to undergo percutaneous coronary intervention [risk ratio (95% confidence interval) - 0.87 (0.86 - 0.89)] or receive secondary prevention at discharge [0.94 (0.93-0.95)]. No in-hospital mortality difference was observed between sexes [1.06 (0.99-1.13) after adjustment]. Over a median follow-up of 8.2 (6.7, 10.1) years, women had higher crude rates of adverse outcomes. After full adjustment, this translated into a lower risk for women compared to men of all-cause mortality [hazard ratio, 0.92 (0.89-0.95)], cardiovascular mortality [0.82 (0.78-0.87)], and cardiovascular events [0.92 (0.88-0.95)]. The female survival advantage seen in general population controls was attenuated in MI patients.
Conclusion: Women were undertreated compared to men after MI. Their survival and outcome benefits may be improved further. Poor outcomes in men despite better receipt of secondary prevention require further attention.
Keywords: Cardiovascular; Mortality; Myocardial infarction; Outcomes; Scotland; Sex.
Plain language summary
We investigated sex disparities in care and outcomes across Scotland amongst men and women admitted for heart attacks. We included all 15 776 women and 31 287 men admitted to hospitals across Scotland between 2010 and 2016, who were followed up until the end of 2021. We analysed their outcomes both in the hospital and over an average follow-up of 8 years after hospital discharge. We also compared them to 81 341 matched healthy people without heart disease. Compared to men, women were older and had more long-term conditions. Women were also less likely to undergo evidence-based treatment for heart attacks. After controlling for other factors, there were no differences between sexes in terms of in-hospital death. Analyses of the long-term follow-up revealed that women were significantly less likely than men to be prescribed treatments aiming to prevent further heart disease or death. Despite this, women had an 8% lower risk of death and an 18% lower risk of dying from heart disease compared to men. Comparisons with the matched healthy population revealed that this ‘female survival advantage’ was less pronounced in people with heart attacks. This suggests that the long-term outcomes of women after heart attacks may be improved further. We also noted that the outcomes in men remain poor despite better treatment, which also requires further attention.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: none declared.
Similar articles
-
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial.J Vasc Surg. 2025 Feb;81(2):366-373.e1. doi: 10.1016/j.jvs.2024.09.031. Epub 2024 Oct 4. J Vasc Surg. 2025. PMID: 39368637 Clinical Trial.
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
-
Beta-blockers for secondary prevention following myocardial infarction in patients without reduced ejection fraction or heart failure: an updated meta-analysis.Eur J Prev Cardiol. 2025 Jun 3;32(8):633-646. doi: 10.1093/eurjpc/zwae298. Eur J Prev Cardiol. 2025. PMID: 39298680
-
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.J Parkinsons Dis. 2025 Jun;15(4):789-804. doi: 10.1177/1877718X251330993. Epub 2025 Apr 29. J Parkinsons Dis. 2025. PMID: 40302366
-
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.Eur J Prev Cardiol. 2017 Sep;24(14):1555-1566. doi: 10.1177/2047487317715769. Epub 2017 Jun 15. Eur J Prev Cardiol. 2017. PMID: 28617620 Free PMC article.
Cited by
-
Predictors of Five-Year Outcomes in Patients with Acute Coronary Syndromes.J Cardiovasc Dev Dis. 2025 Jun 18;12(6):234. doi: 10.3390/jcdd12060234. J Cardiovasc Dev Dis. 2025. PMID: 40558669 Free PMC article.
-
Current anti-inflammatory strategies for treatment of heart failure: From innate to adaptive immunity.Pharmacol Res. 2025 Jun;216:107761. doi: 10.1016/j.phrs.2025.107761. Epub 2025 May 8. Pharmacol Res. 2025. PMID: 40348101 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical